Potential selection of genetically balanced spermatozoa based on the hypo-osmotic swelling test in chromosomal rearrangement carriers. Issue 4 (October 2017)

• Record Type: Journal Article
• Authors: Rouen, Alexandre; Carlier, Léa; Heide, Solveig; Egloff, Matthieu; Marzin, Pauline; Ader, Flavie; Schwartz, Mathias; Rogers, Eli; Joyé, Nicole; Balet, Richard; Lédée, Nathalie; Prat-Ellenberg, Laura; Cassuto, Nino Guy; Siffroi, Jean-Pierre
• Is Part Of: Reproductive biomedicine online. Volume 35:Issue 4(2017)
• Page Start: 372
• Page End: 378
• Publication Date: 2017-10
• Subjects: Chromosome -- HOST -- Hypo-osmotic swelling test -- Rearrangement -- Sperm selection -- Translocation; Human reproductive technology -- Periodicals; Human embryo -- Periodicals; Reproduction -- Periodicals; 616.692
• DOI: 10.1016/j.rbmo.2017.06.017
• Languages: English
• ISSNs: 1472-6483

Abstract

Abstract: Chromosomal translocations and other balanced rearrangements, although usually associated with a normal phenotype, can lead to the transmission of an abnormal unbalanced genome to the offspring. Balanced and unbalanced spermatozoa, being indistinguishable, cannot be selected or deselected for prior to IVF and pre-implantation genetic diagnosis. Spermatozoa from 16 chromosomal rearrangement carriers were studied. After incubation in a hypo-osmotic solution (hypo-osmotic swelling test, or HOST), spermatozoa were fixed on microscope slides. The chromosomally balanced or unbalanced status corresponding to each observed class of flagellar conformation was evaluated through fluorescent in-situ hybridization (FISH). We show here a specific type of spermatozoa, with a distinct flagellar conformation that was associated with a balanced genetic content. HOST is a simple, low-cost and time-honoured procedure initially developed to distinguish immotile viable from non-viable spermatozoa. We demonstrate that it can also be used to identify genetically balanced spermatozoa in chromosomal rearrangement carriers, with a 96% decrease in the proportion of unbalanced spermatozoa after selection. This may potentially improve reproductive prognosis in affected couples if used prior to pre-implantation genetic diagnosis (PGD), and clinical utility and efficacy should be evaluated in further studies.